熱門資訊> 正文
Calidi Biotherapeutics GAAP每股收益为-1.99美元
2025-08-11 18:22
- Cambria Global Asset Allocation ETF(GAA) 0
- WisdomTree Earnings 500 Fund(EPS) 0
- Informatica Inc.(NYSE) 0
- Calidi Biotherapeutics press release (NYSE:CLDI): Q2 GAAP EPS of -$1.99.
- The company had approximately $5.3 million in cash and $0.1 million in restricted cash as of June 30, 2025, compared to $9.6 million in cash and $0.2 million in restricted cash as of December 31, 2024.
More on Calidi Biotherapeutics
- Seeking Alpha’s Quant Rating on Calidi Biotherapeutics
- Historical earnings data for Calidi Biotherapeutics
- Financial information for Calidi Biotherapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
